Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of a Recombinant SARS Vaccine
Protein Sciences Corporation, Meriden, CT, United States
Search grants from Protein Sciences Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Treatment of Binge Eating in Obese Patients in Primary Care
Study of Dsb Derivatives
Single Oral Dose 3'-DEOXY-3'-Fluorothymidine (FLT) in HIV Positive Patients
Information Processing by the Auditory System
Vascular Na Pump Activity and Hypertension
Recently added grants:
Mount Sinai's COFAR Clinical Research Unit and Clinical Trial (The 'ADVANCE' Trial).
Optimization of CMV Vector CD8+ T Cell Response Programming by Modification of Vector Tropism
Optimization of CMV Vector CD8+ T Cell Response Programming by Modification of Vector-Mediated Control of MHC Expression and Ag Processing/Presentation
Optimization of CMV Vector CD8+ T Cell Response Programming by Modification of CMV-Encoded Molecular Mechanisms That Interfere with Unconventional CD8+ T Cell Response Priming
Microbiome and Mucosal Immune Interactions in the Pathogenesis of HIV-1 Transmission
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI30023-11-0-1
Application #
8557621
Study Section
Project Start
2003-05-22
Project End
2012-11-30
Budget Start
Budget End
Support Year
Fiscal Year
2012
Total Cost
$10,718
Indirect Cost
Institution
Name
Protein Sciences Corporation
Department
Type
DUNS #
109124933
City
Meriden
State
CT
Country
United States
Zip Code
06450
Comments
Be the first to comment on this grant